Can-Fite BioPharma Ltd. Investment Income, Net
Can-Fite BioPharma Ltd. (CANF) reported Investment Income, Net of $122.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-03-26
| Period end | Investment Income, Net 6 month | Investment Income, Net 12 month |
|---|---|---|
| 2025-12-31 | $122.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $22.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $250.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $137.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $561.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | $276.00K 6-K · filed 2024-08-29 |